Pages that link to "Q35401667"
Jump to navigation
Jump to search
The following pages link to Metabolic alterations and targeted therapies in prostate cancer (Q35401667):
Displaying 50 items.
- Metabolic Imaging to Assess Treatment Response to Cytotoxic and Cytostatic Agents (Q26740567) (← links)
- A novel approach to the discovery of anti-tumor pharmaceuticals: searching for activators of liponecrosis (Q26774351) (← links)
- Human Prostate Cancer Hallmarks Map (Q26779590) (← links)
- Molecular pathways involved in prostate carcinogenesis: insights from public microarray datasets (Q27990300) (← links)
- Metformin therapy and the risk of colorectal adenoma in patients with type 2 diabetes: A meta-analysis (Q28072501) (← links)
- Inhibition of the LKB1-AMPK pathway by the Epstein-Barr virus-encoded LMP1 promotes proliferation and transformation of human nasopharyngeal epithelial cells (Q29303134) (← links)
- The multifaceted roles of fatty acid synthesis in cancer (Q29694341) (← links)
- A metabolic perturbation by U0126 identifies a role for glutamine in resveratrol-induced cell death (Q30423585) (← links)
- Inhibitor SBFI26 suppresses the malignant progression of castration-resistant PC3-M cells by competitively binding to oncogenic FABP5 (Q33761619) (← links)
- Metformin and longevity (METAL): a window of opportunity study investigating the biological effects of metformin in localised prostate cancer (Q33921635) (← links)
- Novel nuclear localization of fatty acid synthase correlates with prostate cancer aggressiveness (Q33978062) (← links)
- Monoacylglycerol lipase promotes metastases in nasopharyngeal carcinoma (Q34028928) (← links)
- Dietary energy balance modulates prostate cancer progression in Hi-Myc mice (Q34227830) (← links)
- Stromal proteome expression profile and muscle-invasive bladder cancer research (Q34392967) (← links)
- High-calorie diet exacerbates prostate neoplasia in mice with haploinsufficiency of Pten tumor suppressor gene (Q35113473) (← links)
- Curation of the Mammalian Palmitoylome Indicates a Pivotal Role for Palmitoylation in Diseases and Disorders of the Nervous System and Cancers (Q35746623) (← links)
- Lipin-1 regulates cancer cell phenotype and is a potential target to potentiate rapamycin treatment (Q35793782) (← links)
- Butein induces apoptosis and inhibits prostate tumor growth in vitro and in vivo (Q35884596) (← links)
- Statin use as a moderator of metformin effect on risk for prostate cancer among type 2 diabetic patients (Q35898302) (← links)
- Early growth response 1 and fatty acid synthase expression is altered in tumor adjacent prostate tissue and indicates field cancerization (Q35923141) (← links)
- Dysregulated lipid metabolism in cancer (Q36198689) (← links)
- PPARγ isoforms differentially regulate metabolic networks to mediate mouse prostatic epithelial differentiation. (Q36211459) (← links)
- Basic aspects of tumor cell fatty acid-regulated signaling and transcription factors. (Q36294936) (← links)
- Association of fatty-acid synthase polymorphisms and expression with outcomes after radical prostatectomy (Q36570819) (← links)
- Serum lipid profiles and cancer risk in the context of obesity: four meta-analyses (Q36584255) (← links)
- Androgens promote prostate cancer cell growth through induction of autophagy. (Q36932530) (← links)
- Caveolin-1-LRP6 signaling module stimulates aerobic glycolysis in prostate cancer (Q36944221) (← links)
- Association between baseline serum glucose, triglycerides and total cholesterol, and prostate cancer risk categories (Q37045608) (← links)
- Cancer prevention and therapy through the modulation of the tumor microenvironment (Q37058267) (← links)
- High blood sugar levels significantly impact the prognosis of colorectal cancer patients through down-regulation of microRNA-16 by targeting Myb and VEGFR2. (Q37109882) (← links)
- Influence of free fatty acids on glucose uptake in prostate cancer cells (Q37122861) (← links)
- The metastasis inducer CCN1 (CYR61) activates the fatty acid synthase (FASN)-driven lipogenic phenotype in breast cancer cells (Q37298189) (← links)
- Activated lymphocytes as a metabolic model for carcinogenesis. (Q37326607) (← links)
- Multi-level suppression of receptor-PI3K-mTORC1 by fatty acid synthase inhibitors is crucial for their efficacy against ovarian cancer cells (Q37706959) (← links)
- A novel direct activator of AMPK inhibits prostate cancer growth by blocking lipogenesis (Q37710823) (← links)
- Cancer biology and genomics: translating discoveries, transforming pathology (Q37810056) (← links)
- Lipids and prostate cancer (Q38002682) (← links)
- Fatty acid synthase is a potential therapeutic target in estrogen receptor-/progesterone receptor-positive endometrioid endometrial cancer (Q38073079) (← links)
- The fat side of prostate cancer (Q38096735) (← links)
- 18F-Choline, 11C-choline and 11C-acetate PET/CT: comparative analysis for imaging prostate cancer patients (Q38098441) (← links)
- Long-term effects of nanoparticles on nutrition and metabolism (Q38212102) (← links)
- Lactate transporters in the context of prostate cancer metabolism: what do we know? (Q38260136) (← links)
- Synergism between metformin and statins in modifying the risk of biochemical recurrence following radical prostatectomy in men with diabetes (Q38268809) (← links)
- Proinflammatory CXCL12-CXCR4/CXCR7 Signaling Axis Drives Myc-Induced Prostate Cancer in Obese Mice (Q38688881) (← links)
- Metabolic targets for potential prostate cancer therapeutics (Q38747245) (← links)
- Alterations in cellular metabolism modulate CD1d-mediated NKT-cell responses. (Q38764629) (← links)
- Activated α2-macroglobulin binding to human prostate cancer cells triggers insulin-like responses (Q38905777) (← links)
- The fatty acid synthase inhibitor triclosan: repurposing an anti-microbial agent for targeting prostate cancer (Q38948059) (← links)
- Silibinin inhibits aberrant lipid metabolism, proliferation and emergence of androgen-independence in prostate cancer cells via primarily targeting the sterol response element binding protein 1. (Q38949811) (← links)
- Lipid catabolism via CPT1 as a therapeutic target for prostate cancer (Q38966211) (← links)